BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22302084)

  • 1. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
    Dosler S; Gerceker AA
    Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
    Obiang-Obounou BW; Kang OH; Choi JG; Keum JH; Kim SB; Mun SH; Shin DW; Park CB; Kim YG; Han SH; Lee JH; Kwon DY
    Foodborne Pathog Dis; 2011 Aug; 8(8):869-74. PubMed ID: 21524196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria.
    Dosler S; Gerceker AA
    J Chemother; 2012 Jun; 24(3):137-43. PubMed ID: 22759757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS; Shin WS; Kim SK
    J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.
    Dosler S; Mataraci E
    Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA).
    Lin RD; Chin YP; Hou WC; Lee MH
    Planta Med; 2008 Jun; 74(8):840-6. PubMed ID: 18546080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory and bactericidal activity and selection capacity of mutants resistant and tolerant to vancomycin in Staphylococcus aureus strains].
    Villar HE; Tuchscherr L; Arena M; Longo L; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1999 Nov; 17(9):454-7. PubMed ID: 10614079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Guzel C; Savage PB; Gerceker AA
    Chemotherapy; 2011; 57(6):505-10. PubMed ID: 22286090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.